• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质氨肽酶N表达:与非小细胞肺癌血管生成的相关性

Stromal aminopeptidase N expression: correlation with angiogenesis in non-small-cell lung cancer.

作者信息

Ito Shinya, Miyahara Ryo, Takahashi Rei, Nagai Shinjiro, Takenaka Kazumasa, Wada Hiromi, Tanaka Fumihiro

机构信息

Department of Thoracic Surgery, Kyoto University, Japan.

出版信息

Gen Thorac Cardiovasc Surg. 2009 Nov;57(11):591-8. doi: 10.1007/s11748-009-0445-x. Epub 2009 Nov 12.

DOI:10.1007/s11748-009-0445-x
PMID:19908113
Abstract

PURPOSE

Aminopeptidase-N (APN) is a membranebound protein that acts as a zinc-binding protease and participates in extracellular proteolysis. APN plays important roles in tumor progression through promoting invasion and metastasis, prolonging survival of tumor cells, and tumor angiogenesis.

METHODS

We evaluated APN expression in non-small-cell lung cancer patients by immunohistochemistry.

RESULTS

Of the 95 patients reviewed in the present study, 9 (9.5%), all with adenocarcinoma (Ad), showed positive APN expression on the tumors' cells. In all, 31 (32.6%) and 19 (20.0%) patients showed positive APN expression on the tumors' stromal cells (fibroblasts) and microvessels, respectively. APN expression on the tumors' stromal cells was more frequently observed in squamous cell carcinoma patients than in adenocarcinoma patients (P = 0.005). The mean microvessel density (MVD) for APNpositive tumor stromal cells was 59.9, which was significantly higher than that for APN-negative tumor stromal cells (mean MVD 27.4; P = 0.001). The 5-year survival rates for APN-positive and APN-negative tumor stromal cells were 66.0% and 69.8%, respectively, showing no difference in patient survival according to APN status on the tumors' stromal cells.

CONCLUSION

That APN expression on stromal cells was observed predominantly in squamous cell carcinoma may account for the efficacy of ubenimex in the postoperative adjuvant setting for squamous cell carcinoma.

摘要

目的

氨肽酶-N(APN)是一种膜结合蛋白,作为一种锌结合蛋白酶,参与细胞外蛋白水解。APN通过促进侵袭和转移、延长肿瘤细胞存活以及肿瘤血管生成在肿瘤进展中发挥重要作用。

方法

我们通过免疫组织化学评估非小细胞肺癌患者中APN的表达。

结果

在本研究纳入的95例患者中,9例(9.5%)均为腺癌,肿瘤细胞显示APN阳性表达。总共31例(32.6%)和19例(20.0%)患者的肿瘤基质细胞(成纤维细胞)和微血管分别显示APN阳性表达。鳞状细胞癌患者比腺癌患者更频繁地观察到肿瘤基质细胞上的APN表达(P = 0.005)。APN阳性肿瘤基质细胞的平均微血管密度(MVD)为59.9,显著高于APN阴性肿瘤基质细胞(平均MVD 27.4;P = 0.001)。APN阳性和APN阴性肿瘤基质细胞的5年生存率分别为66.0%和69.8%,根据肿瘤基质细胞上的APN状态,患者生存率无差异。

结论

基质细胞上的APN表达主要在鳞状细胞癌中观察到,这可能解释了乌苯美司在鳞状细胞癌术后辅助治疗中的疗效。

相似文献

1
Stromal aminopeptidase N expression: correlation with angiogenesis in non-small-cell lung cancer.基质氨肽酶N表达:与非小细胞肺癌血管生成的相关性
Gen Thorac Cardiovasc Surg. 2009 Nov;57(11):591-8. doi: 10.1007/s11748-009-0445-x. Epub 2009 Nov 12.
2
Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.氨肽酶N/CD13在非小细胞肺癌中的表达及临床意义
J Cancer Res Ther. 2015 Jan-Mar;11(1):223-8. doi: 10.4103/0973-1482.138007.
3
Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.CHD1L的过表达与肺腺癌转移呈正相关,并预示患者预后不良。
Oncotarget. 2015 Oct 13;6(31):31181-90. doi: 10.18632/oncotarget.5070.
4
Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.非小细胞肺癌中基质细胞和癌细胞胸苷磷酸化酶反应性的不同模式:对肿瘤新生血管生成和生存的影响。
Br J Cancer. 1998 May;77(10):1696-703. doi: 10.1038/bjc.1998.280.
5
Clinical significance of aminopeptidase N in non-small cell lung cancer.氨肽酶N在非小细胞肺癌中的临床意义
Clin Cancer Res. 2006 Jul 1;12(13):3971-8. doi: 10.1158/1078-0432.CCR-06-0338.
6
Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.环氧化酶-2(COX-2)的总mRNA水平与非小细胞肺癌患者的血管内皮生长因子mRNA水平、肿瘤血管生成及预后相关。
Int J Cancer. 2005 Jul 1;115(4):545-55. doi: 10.1002/ijc.20898.
7
Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.肿瘤血管生成预测Ⅰ期肺癌患者的生存。
J Thorac Cardiovasc Surg. 2010 Nov;140(5):996-1000. doi: 10.1016/j.jtcvs.2010.07.002. Epub 2010 Aug 13.
8
Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer.基质成纤维细胞而非肿瘤细胞中的基质金属蛋白酶-2状态是非小细胞肺癌的一个重要预后因素。
Clin Cancer Res. 2004 Oct 1;10(19):6579-85. doi: 10.1158/1078-0432.CCR-04-0272.
9
Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.缺氧诱导碳酸酐酶-9的表达与血管生成途径相关,且在非小细胞肺癌中独立地与不良预后相关。
Cancer Res. 2001 Nov 1;61(21):7992-8.
10
[Postoperative adjuvant therapy in combined lung cancer treatment].[联合肺癌治疗中的术后辅助治疗]
Medicina (Kaunas). 2004;40 Suppl 1:156-60.

引用本文的文献

1
Scandium-44: Diagnostic Feasibility in Tumor-Related Angiogenesis.钪-44:肿瘤相关血管生成中的诊断可行性。
Int J Mol Sci. 2023 Apr 17;24(8):7400. doi: 10.3390/ijms24087400.
2
Therapeutic Performance Evaluation of Bi-Labelled Aminopeptidase N (APN/CD13)-Affine NGR-Motif ([Bi]Bi-DOTAGA-cKNGRE) in Experimental Tumour Model: A Treasured Tailor for Oncology.双标记氨肽酶N(APN/CD13)亲和性NGR基序([Bi]Bi-DOTAGA-cKNGRE)在实验性肿瘤模型中的治疗性能评估:肿瘤学的珍贵定制方案
Pharmaceutics. 2023 Feb 1;15(2):491. doi: 10.3390/pharmaceutics15020491.
3
Identification of potential target genes of non-small cell lung cancer in response to resveratrol treatment by bioinformatics analysis.

本文引用的文献

1
Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.氨肽酶N(APN)/CD13抑制剂乌苯美司可增强人宫颈癌的放射敏感性。
BMC Cancer. 2008 Mar 19;8:74. doi: 10.1186/1471-2407-8-74.
2
Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer.基质成纤维细胞而非肿瘤细胞中的基质金属蛋白酶-2状态是非小细胞肺癌的一个重要预后因素。
Clin Cancer Res. 2004 Oct 1;10(19):6579-85. doi: 10.1158/1078-0432.CCR-04-0272.
3
Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients.
通过生物信息学分析鉴定白藜芦醇治疗非小细胞肺癌的潜在靶基因。
Aging (Albany NY). 2021 Oct 11;13(19):23245-23261. doi: 10.18632/aging.203616.
4
Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer.小细胞肺癌分子靶向治疗的未来选择
Cancers (Basel). 2019 May 17;11(5):690. doi: 10.3390/cancers11050690.
5
Melflufen - a peptidase-potentiated alkylating agent in clinical trials.美法仑氟芬 - 一种正在进行临床试验的肽酶增强型烷化剂。
Oncotarget. 2017 Jun 8;8(39):66641-66655. doi: 10.18632/oncotarget.18420. eCollection 2017 Sep 12.
6
Potential therapeutic impact of CD13 expression in non-small cell lung cancer.CD13表达在非小细胞肺癌中的潜在治疗作用
PLoS One. 2017 Jun 12;12(6):e0177146. doi: 10.1371/journal.pone.0177146. eCollection 2017.
7
MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model.MT95-4是一种针对氨肽酶N产生的全人源化抗体,可降低小鼠模型中的肿瘤进展。
Cancer Sci. 2015 Jul;106(7):921-8. doi: 10.1111/cas.12692. Epub 2015 May 29.
8
Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment.肿瘤微环境中非恶性和癌细胞表达的氨基肽酶 N(CD13)的协同作用。
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1637-42. doi: 10.1073/pnas.1120790109. Epub 2012 Jan 17.
9
Glutathione degradation by the alternative pathway (DUG pathway) in Saccharomyces cerevisiae is initiated by (Dug2p-Dug3p)2 complex, a novel glutamine amidotransferase (GATase) enzyme acting on glutathione.酵母中谷胱甘肽通过非经典途径(DUG 途径)降解,是由(Dug2p-Dug3p)2 复合物起始的,该复合物是一种作用于谷胱甘肽的新型谷氨酰胺转氨酶(GATase)酶。
J Biol Chem. 2012 Mar 16;287(12):8920-31. doi: 10.1074/jbc.M111.327411. Epub 2012 Jan 25.
10
Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues.在炎症和肿瘤组织的血管中增强 CD13 的表达。
J Histochem Cytochem. 2011 Jan;59(1):47-59. doi: 10.1369/jhc.2010.956644.
非小细胞肺癌患者肿瘤细胞和基质巨噬细胞中VEGF-C状态的临床意义
Br J Cancer. 2004 Aug 2;91(3):498-503. doi: 10.1038/sj.bjc.6601992.
4
Randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma.对已切除的Ⅰ期肺鳞状细胞癌患者进行的关于抑氨肽酶B的随机双盲安慰剂对照试验。
J Natl Cancer Inst. 2003 Apr 16;95(8):605-10. doi: 10.1093/jnci/95.8.605.
5
Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma.氨肽酶N/CD13在人胰腺癌中的表达的临床意义
Clin Cancer Res. 2003 Apr;9(4):1503-8.
6
Expression of angiopoietins and its clinical significance in non-small cell lung cancer.血管生成素在非小细胞肺癌中的表达及其临床意义
Cancer Res. 2002 Dec 1;62(23):7124-9.
7
Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer.氨肽酶N参与细胞运动和血管生成:其在人类结肠癌中的临床意义。
Gastroenterology. 2002 Feb;122(2):376-86. doi: 10.1053/gast.2002.31095.
8
Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells.含NGR基序的药物与肿瘤血管、上皮细胞和髓样细胞中CD13亚型的差异结合。
Cancer Res. 2002 Feb 1;62(3):867-74.
9
Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.非小细胞肺癌中血管生成的评估:抗CD34抗体与抗CD105抗体的比较。
Clin Cancer Res. 2001 Nov;7(11):3410-5.
10
Neutral endopeptidase/CD10 and aminopeptidase N/CD13 gene expression as a prognostic factor in non-small cell lung cancer.中性内肽酶/CD10和氨肽酶N/CD13基因表达作为非小细胞肺癌的预后因素
Jpn J Thorac Cardiovasc Surg. 2001 Aug;49(8):489-96. doi: 10.1007/BF02919543.